Article

AIDS-related Kaposi's sarcoma: state of the art and therapeutic strategies

Department of Medical Oncology, National Cancer Institute, Aviano (PN), Italy.
Current HIV research (Impact Factor: 2.14). 11/2009; 7(6):634-8. DOI: 10.2174/157016209789973619
Source: PubMed

ABSTRACT In the HAART era Kaposi's sarcoma (KS) remains the second most frequent tumor in HIV-infected patients worldwide, and it has become the most common cancer in Sub-Saharan Africa. In western countries the risk for KS in men having sex with men (MSM) is 5 to 10 times higher compared to other groups of individuals practicing other HIV-risk behaviors. Patients with KS in Sub-Saharan Africa have very high tumor burdens and rapid disease progression with a diminished life expectancy of less than 6 months. KS lesions are comprised of both distinctive spindle cells of endothelial origin and a variable inflammatory infiltrate, which suggests that KS may result from reactive hyperproliferation induced by chronic inflammation, and therefore it is not a true neoplasm. KS has a variable clinical course ranging from very indolent forms, requiring no or minimal therapy, to a rapidly progressive disease. Treatment decisions must take into consideration the extent and the rate of tumor growth, patient's symptoms, immune system conditions and concurrent HIV-related complications. Several different therapeutic options are available but the optimal therapy is still unclear. Highly Active Antiretroviral Therapy (HAART) including protease inhibitors (PI) may represent the first treatment step for slowly progressive disease; chemotherapy (CT) plus HAART is indicated for visceral and/or rapidly progressive disease, whereas maintenance (M)-HAART after systemic chemotherapy may be an effective anti-KS measure after debulking CT. The angiogenic nature of KS makes it particularly suitable for therapies based on targeted agents such as metalloproteinase inhibitors, angiogenesis inhibitors and tyrosine kinase inhibitors. The aim of this article is to provide an up-to-date review of the current status and perspectives of AIDS-related KS in the HAART era.

Download full-text

Full-text

Available from: Massimiliano Berretta, Aug 10, 2015
2 Followers
 · 
211 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: The coupling coefficient and resonant frequency shift of dual modes induced by the internal perturbation are obtained theoretically for a general circular resonator. They are used for the design of a two-stage BPF together with the external Q also theoretically derived. The frequency and the appearance condition of the intrinsic attenuation poles at both sides of the passband are analyzed in a simple form
    Microwave Conference Proceedings, 1997. APMC '97, 1997 Asia-Pacific; 01/1998
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Recent developments in Si based tunnel diode technologies have made the realization of circuits incorporating both tunnel diodes and transistors feasible. A recent study by the authors presented the design of an n-on-p Si RITD layer with a peak-to-valley current ratio (PVCR) of 2.15 at a current density of 3 kA/cm<sup>2</sup> which was grown by molecular beam epitaxy (MBE) (Thompson et al, Appl. Phys. Lett. vol. 75, pp. 1308-1310, 1999). Further studies of this structure investigated additional tunnel barrier thicknesses of 4 nm, 8 nm, and 10 nm. In all samples, room temperature NDR was observed comparable to that of the baseline 6 nm RITD. Simple adjustments to the tunnel barrier thickness can be made to tailor the performance for a particular circuit application. However, growth of a complimentary p-on-n tunnel diode is problematic due to Sb segregation through the intrinsic tunneling spacer. The solution is to control the Sb segregation by employing multiple substrate temperatures during MBE growth. Following the success of the complementary p-on-n growth strategy, it was now possible to demonstrate the integration of two tunnel diodes in a single growth. The basic flow and design presented here follow that of III-V RITDs (Yang et al, 1995), presenting a symmetric pnp RITD structure. The motivation for developing this structure was to mimic the I-V characteristic of III-V RITDs which have NDR regions under forward and reverse bias. A Si-based structure with these properties would facilitate the development of a Goto-type memory cell (Goto et al, 1960)
    Device Research Conference, 2000. Conference Digest. 58th DRC; 02/2000
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Classic Kaposi sarcoma (KS) is exceedingly rare in children from the Mediterranean Basin, despite the high prevalence of human herpesvirus-8 (HHV-8) infection in this region. We hypothesized that rare single-gene inborn errors of immunity to HHV-8 may underlie classic KS in childhood. We investigated a child with no other unusually severe infectious or tumoral phenotype who died from disseminated KS at two years of age. Whole-exome sequencing in the patient revealed a homozygous splice-site mutation in STIM1, the gene encoding stromal interaction molecule 1, which regulates store-operated Ca(2+) entry. STIM1 mRNA splicing, protein production, and Ca(2+) influx were completely abolished in EBV-transformed B cell lines from the patient, but were rescued by the expression of wild-type STIM1. Based on the previous discovery of STIM1 deficiency in a single family with a severe T cell immunodeficiency and the much higher risk of KS in individuals with acquired T cell deficiencies, we conclude that STIM1 T cell deficiency precipitated the development of lethal KS in this child upon infection with HHV-8. Our report provides the first evidence that isolated classic KS in childhood may result from single-gene defects and provides proof-of-principle that whole-exome sequencing in single patients can decipher the genetic basis of rare inborn errors.
    Journal of Experimental Medicine 09/2010; 207(11):2307-12. DOI:10.1084/jem.20101597 · 13.91 Impact Factor
Show more